The Emory Transplant Center performed its first liver transplant from an HIV-positive deceased donor to an HIV-positive recipient. The procedure is not only the first successful HIV-positive to HIV-positive liver transplant in Georgia, but it is also the first in the Southeast.
In November 2013, the HOPE Act, a policy allowing organ donation between two HIV positive individuals, was signed by President Obama. This Act became effective in November 2015, authorizing transplantation clinical trials between HIV-positive donors and transplant recipients.
Previously, organs from HIV-positive donors were discarded, despite the fact they were often well-functioning and capable of saving lives. Through the HOPE Act, Emory Transplant Center and 21 other centers nationwide are taking part in the HOPE in Action clinical trial — a prospective study evaluating the safety of HIV-positive deceased donor kidney and liver transplants in HIV-positive recipients. Complications that may arise post-transplant are studied too. It is important to note, these organs are never transplanted into HIV-negative recipients.
“More than 7,000 Americans die annually while waiting for an organ transplant, highlighting the critical need to expand the donor organ supply,” says William Kitchens, MD, PhD, assistant professor of Emory University and a liver transplant surgeon at Emory Healthcare. “The HOPE Act makes an important contribution to solving this medical crisis, as previously these organs from HIV-positive donors were discarded, despite the fact that they were often well-functioning and capable of saving lives. Across the nation, more than 200 HIV-positive recipients are now enrolled in the HOPE Act trial to potentially receive HIV-positive donor organs, and we expect this number to continue to grow.”
